Spanish Professional Services Stock News

BME:PHM
BME:PHMBiotechs

Pharma Mar (BME:PHM) Could Be 37% Below Fair Value Following Weak Half Year Earnings

Pharma Mar (BME:PHM) is in focus after reporting first half 2026 net income of €0.561 million compared with €19.42 million a year earlier, with earnings per share from continuing operations also sharply lower. See our latest analysis for Pharma Mar. Pharma Mar's latest earnings update arrived after a weak patch for the stock, with a 90 day share price return down 21.21% and a 30 day share price return down 3.98%. However, the €78.4 share price still sits above levels implied by its 140.97%...
BME:CLNX
BME:CLNXTelecom

Could Cellnex Telecom (BME:CLNX) Be 24% Undervalued After Half Year 2026 Results?

Cellnex Telecom (BME:CLNX) drew fresh attention after reporting half year 2026 results on 30 July, with revenue of €2,208.75 million and a reduced net loss of €97.3 million compared with last year. See our latest analysis for Cellnex Telecom. The earnings update appears to have supported a short burst of interest in Cellnex Telecom, with a 1-day share price return of 2.84% and a 1-month share price return of 9.06%. However, the 1-year total shareholder return is still down 5.76%, which points...
BME:FAE
BME:FAEPharmaceuticals

European Penny Stocks To Watch In August 2026

The European stock markets have shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs amid strong corporate earnings and renewed interest in AI-related stocks. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their potential for significant returns. Although the term 'penny stock' might seem outdated, these investments can still uncover hidden value when focused on companies with solid...
BME:ART
BME:ARTElectrical

Is Arteche Lantegi Elkartea (BME:ART) Undervalued On Strong Half Year 2026 Results?

Arteche Lantegi Elkartea (BME:ART) has drawn fresh attention after reporting half year 2026 results with sales of €281.85 million and net income of €30.56 million, both higher than the prior period. See our latest analysis for Arteche Lantegi Elkartea. The latest half year earnings have arrived after a sharp share price pullback, with Arteche Lantegi Elkartea showing a 30 day share price return down 11.46% and a 90 day share price return down 35.00%, yet a year to date share price gain of...
BME:RED
BME:REDElectric Utilities

Is Redeia Corporación (BME:RED) Fairly Valued As Fresh 2026 Guidance Follows Half Year Results?

Redeia Corporación stock reaction to fresh 2026 guidance and half year numbers Redeia Corporación (BME:RED) has been in focus after releasing half year 2026 results, alongside guidance that points to net profit above €510 million and gives investors updated information on the company’s earnings profile. See our latest analysis for Redeia Corporación. At a share price of €15.45, Redeia Corporación has seen a 90 day share price return of 5.97%, while the 3 year total shareholder return of...
BME:FDR
BME:FDRMachinery

Fluidra (BME:FDR) Launches A Buyback And Posts Higher Revenue, Is It Undervalued?

Fluidra (BME:FDR) has drawn renewed attention to its stock after announcing a share repurchase program of up to €40 million, alongside half-year 2026 results that report higher revenue and lower net income. See our latest analysis for Fluidra. Despite the new buyback plan and Fluidra’s latest half year results, recent momentum is mixed, with a 7 day share price return of 5.3%, a year to date share price return that is down 15.5%, and a 1 year total shareholder return that is down 8.4%. If...
BME:BKT
BME:BKTBanks

Bankinter (BME:BKT) Rises On Strong H1 Results As Fair Value Looks Close

Bankinter (BME:BKT) has just combined stronger half year 2026 earnings with a new €1b floating rate bond maturing in 2033. Together, these moves provide investors with updated information on profitability and funding. See our latest analysis for Bankinter. Bankinter’s recent bond issue and half year 2026 results arrive after a steady run in the stock, with a 30 day share price return of 6.3% and a 1 year total shareholder return of 32.87%. The multi year total shareholder return, which is...
BME:MEL
BME:MELHospitality

Meliá Hotels International (BME:MEL) Could Be 6% Undervalued On H1 Results And Cuba Charge

Meliá Hotels International (BME:MEL) stock is back in focus after the company reported first half 2026 results, combining higher revenue with a small net loss driven by a one off non cash Cuba related impairment. See our latest analysis for Meliá Hotels International. After the half year 2026 results and Cuba related impairment, Meliá Hotels International’s share price has eased recently, with a 30 day share price return showing a 13% decline. However, the year to date share price return of...
BME:GRF
BME:GRFBiotechs

Is Grifols (BME:GRF) A Bargain On Mixed Half Year Earnings?

Grifols (BME:GRF) has been in focus after its half year 2026 report showed sales of €3,574 million compared to €3,677 million a year earlier, while net income reached €227 million against €177 million. See our latest analysis for Grifols. The recent half year 2026 report appears to have been the key driver behind Grifols’ 13.11% 1 month share price return and 12.41% 3 month share price return, although the total shareholder return over 1 and 5 years remains sharply lower. This suggests...
BME:AMS
BME:AMSHospitality

Amadeus IT Group (BME:AMS) Lifted 2026 Revenue Guidance, Is The Stock Still Cheap?

Amadeus IT Group (BME:AMS) has come into focus after revising its 2026 earnings guidance, with expectations for group revenue growth now framed in a mid to high single digit range. See our latest analysis for Amadeus IT Group. The revised 2026 outlook arrives after a period where Amadeus IT Group’s recent momentum has picked up, with a 1 month share price return of 10.57% and a 3 month share price return of 12.59%. However, the year to date share price return is down 9.92% and the 1 year...
BME:SAN
BME:SANBanks

How Investors Are Reacting To Banco Santander (BME:SAN) Surging Half-Year Net Income To €8.97 Billion

Banco Santander, S.A. has released its half-year results for the period ended June 30, 2026, reporting net income of €8.97 billion, up from €6.83 billion a year earlier. This sharp increase in earnings highlights how the bank’s current business mix and cost base are converting revenue into higher bottom-line profit. Next, we’ll examine how this sharp half-year net income increase reshapes Banco Santander’s investment narrative and future earnings assumptions. The future of work is here...
BME:IBE
BME:IBEElectric Utilities

Will Iberdrola's (BME:IBE) Stronger H1 2026 Earnings Shift Its Profitability Narrative?

Iberdrola, S.A. has released its half‑year 2026 results, reporting sales of €22,469.1 million and net income of €4,336.4 million, both higher than the same period in 2025. Basic earnings per share rose from €0.535 to €0.622, pointing to stronger profitability and efficiency in converting revenue into shareholder earnings. With earnings per share improving over the half year, we’ll explore how this development interacts with Iberdrola’s existing investment narrative. The future of work is...
BME:LDA
BME:LDAInsurance

Línea Directa Aseguradora (BME:LDA) Posted Stronger Half Year Earnings, Is It Still A Bargain?

Línea Directa Aseguradora Compañía de Seguros y Reaseguros (BME:LDA) recently released its half-year 2026 results, reporting net income of €52.1 million and earnings per share of €0.05 from continuing operations. See our latest analysis for Línea Directa Aseguradora Compañía de Seguros y Reaseguros. The half year update appears to sit alongside firm price momentum, with Línea Directa Aseguradora Compañía de Seguros y Reaseguros posting a 1 month share price return of 8.94% and a year to date...
BME:TEF
BME:TEFTelecom

Telefónica (BME:TEF) Reports Higher Sales And A Narrower Loss, Is It Still Below Fair Value?

Telefónica (BME:TEF) is back in focus after reporting half year 2026 results on 29 July, with slightly higher sales and a much smaller net loss compared with the prior year period. See our latest analysis for Telefónica. The earnings update appears to have given Telefónica some support, with a 1-day share price return of 2.23% and a year-to-date share price return of 5.26%. However, the 1-year total shareholder return is still down 14.5%, while longer term total shareholder returns over three...
BME:VIS
BME:VISFood

3 Food Stocks Watching Olive Oil And Crop Supply Shocks

When extreme heat, drought and wildfires start to squeeze olive groves and crop fields across Europe, the impact does not stop at the farm gate. It can change pricing power, cost pressures and risk profiles for listed agricultural producers. This article looks at how that backdrop links to three stocks exposed to the latest weather driven shocks in olive oil and key food crops. You see which companies could stand to benefit from tighter supply and where operational resilience really matters,...
BME:EBRO
BME:EBROFood

Ebro Foods (BME:EBRO) Could Be 54% Undervalued As Earnings And US Deal Draw Focus

Ebro Foods (BME:EBRO) has drawn fresh attention after reporting half-year 2026 earnings, with sales of €1,476.25 million compared with €1,533.4 million a year earlier and net income of €103.88 million compared with €96.99 million. See our latest analysis for Ebro Foods. At a share price of €18.46, Ebro Foods has delivered a 1-year total shareholder return of 11.41% and a 5-year total shareholder return of 29.30%. This suggests steady compounding, while recent earnings and the Saint Charles...
BME:OHLA
BME:OHLAConstruction

European Penny Stocks To Watch In August 2026

The European market has shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs, driven by robust corporate earnings and renewed interest in AI-related stocks. In this context, penny stocks—though often seen as a throwback to earlier market times—continue to capture investor interest due to their potential for growth at an accessible price point. These smaller or newer companies can offer significant value when they possess strong financials and clear growth prospects.